Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1393 to 1404 of 3124 entries
Sorted by: Best Match Show Resources per page
Psychographic Segmentation: Another Lever for Precision Population Brain Health.

Frontiers in aging neuroscience

Smith E, Ibanez A, Lavretsky H, Berk M, Eyre HA.
PMID: 34955814
Front Aging Neurosci. 2021 Dec 08;13:783297. doi: 10.3389/fnagi.2021.783297. eCollection 2021.

Dementia prevention interventions that address modifiable risk factors for dementia require extensive lifestyle and behavior changes. Strategies are needed to enhance engagement and personalization of the experience at a population level. Precision Population Brain Health aims to improve brain...

Cite
Smith E, Ibanez A, Lavretsky H, et al. Psychographic Segmentation: Another Lever for Precision Population Brain Health. Front Aging Neurosci. 2021;13:783297doi: 10.3389/fnagi.2021.783297.
Smith, E., Ibanez, A., Lavretsky, H., Berk, M., & Eyre, H. A. (2021). Psychographic Segmentation: Another Lever for Precision Population Brain Health. Frontiers in aging neuroscience, 13783297. https://doi.org/10.3389/fnagi.2021.783297
Smith, Erin, et al. "Psychographic Segmentation: Another Lever for Precision Population Brain Health." Frontiers in aging neuroscience vol. 13 (2021): 783297. doi: https://doi.org/10.3389/fnagi.2021.783297
Smith E, Ibanez A, Lavretsky H, Berk M, Eyre HA. Psychographic Segmentation: Another Lever for Precision Population Brain Health. Front Aging Neurosci. 2021 Dec 08;13:783297. doi: 10.3389/fnagi.2021.783297. eCollection 2021. PMID: 34955814; PMCID: PMC8692771.
Copy Download .nbib Format: NLM
Partial Polymer Blend for Fused Filament Fabrication with High Thermal Stability.

Polymers

Harris M, Potgieter J, Mohsin H, Chen JQ, Ray S, Arif KM.
PMID: 34641168
Polymers (Basel). 2021 Sep 30;13(19). doi: 10.3390/polym13193353.

The materials for large scale fused filament fabrication (FFF) are not yet designed to resist thermal degradation. This research presents a novel polymer blend of polylactic acid with polypropylene for FFF, purposefully designed with minimum feasible chemical grafting and...

Cite
Harris M, Potgieter J, Mohsin H, et al. Partial Polymer Blend for Fused Filament Fabrication with High Thermal Stability. Polymers (Basel). 2021;13(19)doi: 10.3390/polym13193353.
Harris, M., Potgieter, J., Mohsin, H., Chen, J. Q., Ray, S., & Arif, K. M. (2021). Partial Polymer Blend for Fused Filament Fabrication with High Thermal Stability. Polymers, 13(19), . https://doi.org/10.3390/polym13193353
Harris, Muhammad, et al. "Partial Polymer Blend for Fused Filament Fabrication with High Thermal Stability." Polymers vol. 13,19 (2021). doi: https://doi.org/10.3390/polym13193353
Harris M, Potgieter J, Mohsin H, Chen JQ, Ray S, Arif KM. Partial Polymer Blend for Fused Filament Fabrication with High Thermal Stability. Polymers (Basel). 2021 Sep 30;13(19). doi: 10.3390/polym13193353. PMID: 34641168; PMCID: PMC8512697.
Copy Download .nbib Format: NLM
The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot.

CJC open

Kawada S, Chakraborty P, Downar E, Sanchez AP, Sathananthan G, Bhaskaran A, Kugamoorthy P, Albertini L, Oechslin EN, Silversides C, Wald RM, Roche SL, Swan L, Alonso-Gonzalez R, Thorne S, Harris L, Hickey E, Nanthakumar K, Mondésert B, Khairy P, Nair K.
PMID: 34027366
CJC Open. 2021 Jan 28;3(5):619-626. doi: 10.1016/j.cjco.2021.01.005. eCollection 2021 May.

BACKGROUND: Implantable cardioverter defibrillators (ICDs) are effective in preventing arrhythmic sudden cardiac death in patients with tetralogy of Fallot (TOF). Although ICD therapies for malignant ventricular arrhythmias can be life-saving, shocks could have deleterious consequences. Substrate-based ablation therapy has...

Cite
Kawada S, Chakraborty P, Downar E, et al. The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot. CJC Open. 2021;3(5):619-626doi: 10.1016/j.cjco.2021.01.005.
Kawada, S., Chakraborty, P., Downar, E., Sanchez, A. P., Sathananthan, G., Bhaskaran, A., Kugamoorthy, P., Albertini, L., Oechslin, E. N., Silversides, C., Wald, R. M., Roche, S. L., Swan, L., Alonso-Gonzalez, R., Thorne, S., Harris, L., Hickey, E., Nanthakumar, K., Mondésert, B., Khairy, P., & Nair, K. (2021). The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot. CJC open, 3(5), 619-626. https://doi.org/10.1016/j.cjco.2021.01.005
Kawada, Satoshi, et al. "The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot." CJC open vol. 3,5 (2021): 619-626. doi: https://doi.org/10.1016/j.cjco.2021.01.005
Kawada S, Chakraborty P, Downar E, Sanchez AP, Sathananthan G, Bhaskaran A, Kugamoorthy P, Albertini L, Oechslin EN, Silversides C, Wald RM, Roche SL, Swan L, Alonso-Gonzalez R, Thorne S, Harris L, Hickey E, Nanthakumar K, Mondésert B, Khairy P, Nair K. The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot. CJC Open. 2021 Jan 28;3(5):619-626. doi: 10.1016/j.cjco.2021.01.005. eCollection 2021 May. PMID: 34027366; PMCID: PMC8134918.
Copy Download .nbib Format: NLM
NRF2 activation inhibits valproic acid-induced neural tube defects in mice.

Neurotoxicology and teratology

Piorczynski TB, Lapehn S, Ringer KP, Allen SA, Johnson GA, Call K, Lucas SM, Harris C, Hansen JM.
PMID: 34737154
Neurotoxicol Teratol. 2021 Oct 29;89:107039. doi: 10.1016/j.ntt.2021.107039. Epub 2021 Oct 29.

Valproic acid (VPA) is a widely prescribed medication that has traditionally been used to treat epilepsy, yet embryonic exposure to VPA increases the risk of the fetus developing neural tube defects (NTDs). While the mechanism by which VPA causes...

Cite
Piorczynski TB, Lapehn S, Ringer KP, et al. NRF2 activation inhibits valproic acid-induced neural tube defects in mice. Neurotoxicol Teratol. 2021;89:107039doi: 10.1016/j.ntt.2021.107039.
Piorczynski, T. B., Lapehn, S., Ringer, K. P., Allen, S. A., Johnson, G. A., Call, K., Lucas, S. M., Harris, C., & Hansen, J. M. (2021). NRF2 activation inhibits valproic acid-induced neural tube defects in mice. Neurotoxicology and teratology, 89107039. https://doi.org/10.1016/j.ntt.2021.107039
Piorczynski, Ted B, et al. "NRF2 activation inhibits valproic acid-induced neural tube defects in mice." Neurotoxicology and teratology vol. 89 (2021): 107039. doi: https://doi.org/10.1016/j.ntt.2021.107039
Piorczynski TB, Lapehn S, Ringer KP, Allen SA, Johnson GA, Call K, Lucas SM, Harris C, Hansen JM. NRF2 activation inhibits valproic acid-induced neural tube defects in mice. Neurotoxicol Teratol. 2021 Oct 29;89:107039. doi: 10.1016/j.ntt.2021.107039. Epub 2021 Oct 29. PMID: 34737154.
Copy Download .nbib Format: NLM
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.

Vaccines

Harris PE, Brasel T, Massey C, Herst CV, Burkholz S, Lloyd P, Blankenberg T, Bey TM, Carback R, Hodge T, Ciotlos S, Wang L, Comer JE, Rubsamen RM.
PMID: 34070152
Vaccines (Basel). 2021 May 18;9(5). doi: 10.3390/vaccines9050520.

BACKGROUND: Persistent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has given rise to a COVID-19 pandemic. Several vaccines, conceived in 2020, that evoke protective spike antibody responses are being deployed in mass public health vaccination programs. Recent...

Cite
Harris PE, Brasel T, Massey C, et al. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines (Basel). 2021;9(5)doi: 10.3390/vaccines9050520.
Harris, P. E., Brasel, T., Massey, C., Herst, C. V., Burkholz, S., Lloyd, P., Blankenberg, T., Bey, T. M., Carback, R., Hodge, T., Ciotlos, S., Wang, L., Comer, J. E., & Rubsamen, R. M. (2021). A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines, 9(5), . https://doi.org/10.3390/vaccines9050520
Harris, Paul E, et al. "A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques." Vaccines vol. 9,5 (2021). doi: https://doi.org/10.3390/vaccines9050520
Harris PE, Brasel T, Massey C, Herst CV, Burkholz S, Lloyd P, Blankenberg T, Bey TM, Carback R, Hodge T, Ciotlos S, Wang L, Comer JE, Rubsamen RM. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines (Basel). 2021 May 18;9(5). doi: 10.3390/vaccines9050520. PMID: 34070152; PMCID: PMC8158516.
Copy Download .nbib Format: NLM
Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial.

JAMA network open

Ljubenkov PA, Edwards L, Iaccarino L, La Joie R, Rojas JC, Koestler M, Harris B, Boeve BF, Borroni B, van Swieten JC, Grossman M, Pasquier F, Frisoni GB, Mummery CJ, Vandenberghe R, Le Ber I, Hannequin D, McGinnis SM, Auriacombe S, Onofrj M, Goodman IJ, Riordan HJ, Wisniewski G, Hesterman J, Marek K, Haynes BA, Patzke H, Koenig G, Hilt D, Moebius H, Boxer AL.
PMID: 34559230
JAMA Netw Open. 2021 Sep 01;4(9):e2125584. doi: 10.1001/jamanetworkopen.2021.25584.

IMPORTANCE: Histone deacetylase inhibitors have been repeatedly shown to elevate progranulin levels in preclinical models. This report describes the first randomized clinical trial of a histone deacetylase inhibitor in frontotemporal dementia (FTD) resulting from progranulin (GRN) gene variations.OBJECTIVE: To...

Cite
Ljubenkov PA, Edwards L, Iaccarino L, et al. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(9):e2125584doi: 10.1001/jamanetworkopen.2021.25584.
Ljubenkov, P. A., Edwards, L., Iaccarino, L., La Joie, R., Rojas, J. C., Koestler, M., Harris, B., Boeve, B. F., Borroni, B., van Swieten, J. C., Grossman, M., Pasquier, F., Frisoni, G. B., Mummery, C. J., Vandenberghe, R., Le Ber, I., Hannequin, D., McGinnis, S. M., Auriacombe, S., Onofrj, M., Goodman, I. J., Riordan, H. J., Wisniewski, G., Hesterman, J., Marek, K., Haynes, B. A., Patzke, H., Koenig, G., Hilt, D., Moebius, H., & Boxer, A. L. (2021). Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial. JAMA network open, 4(9), e2125584. https://doi.org/10.1001/jamanetworkopen.2021.25584
Ljubenkov, Peter A, et al. "Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial." JAMA network open vol. 4,9 (2021): e2125584. doi: https://doi.org/10.1001/jamanetworkopen.2021.25584
Ljubenkov PA, Edwards L, Iaccarino L, La Joie R, Rojas JC, Koestler M, Harris B, Boeve BF, Borroni B, van Swieten JC, Grossman M, Pasquier F, Frisoni GB, Mummery CJ, Vandenberghe R, Le Ber I, Hannequin D, McGinnis SM, Auriacombe S, Onofrj M, Goodman IJ, Riordan HJ, Wisniewski G, Hesterman J, Marek K, Haynes BA, Patzke H, Koenig G, Hilt D, Moebius H, Boxer AL. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial. JAMA Netw Open. 2021 Sep 01;4(9):e2125584. doi: 10.1001/jamanetworkopen.2021.25584. PMID: 34559230; PMCID: PMC8463943.
Copy Download .nbib Format: NLM
Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice.

Neurology. Clinical practice

Hersh CM, Harris H, Conway D, Hua LH.
PMID: 33510948
Neurol Clin Pract. 2020 Dec;10(6):e53-e65. doi: 10.1212/CPJ.0000000000000809.

OBJECTIVE: To assess the real-world comparative effectiveness of switching from natalizumab (NTZ) to a moderate-efficacy (Mod) disease-modifying therapy (DMT) vs high-efficacy therapy (HET) in patients with multiple sclerosis (MS).METHODS: Patients discontinuing NTZ at two MS centers (n = 556)...

Cite
Hersh CM, Harris H, Conway D, et al. Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice. Neurol Clin Pract. 2020;10(6):e53-e65doi: 10.1212/CPJ.0000000000000809.
Hersh, C. M., Harris, H., Conway, D., & Hua, L. H. (2020). Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice. Neurology. Clinical practice, 10(6), e53-e65. https://doi.org/10.1212/CPJ.0000000000000809
Hersh, Carrie M, et al. "Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice." Neurology. Clinical practice vol. 10,6 (2020): e53-e65. doi: https://doi.org/10.1212/CPJ.0000000000000809
Hersh CM, Harris H, Conway D, Hua LH. Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice. Neurol Clin Pract. 2020 Dec;10(6):e53-e65. doi: 10.1212/CPJ.0000000000000809. PMID: 33510948; PMCID: PMC7837445.
Copy Download .nbib Format: NLM
Engineering temporal dynamics in microbial communities.

Current opinion in microbiology

Ronda C, Wang HH.
PMID: 34739926
Curr Opin Microbiol. 2021 Oct 30;65:47-55. doi: 10.1016/j.mib.2021.10.009. Epub 2021 Oct 30.

Microbial communities are a key part to tackling global challenges in human health, environmental conservation, and sustainable agriculture in the coming decade. Recent advances in synthetic biology to study and modify microbial communities have led to important insights into...

Cite
Ronda C, Wang HH. Engineering temporal dynamics in microbial communities. Curr Opin Microbiol. 2021;65:47-55doi: 10.1016/j.mib.2021.10.009.
Ronda, C., & Wang, H. H. (2021). Engineering temporal dynamics in microbial communities. Current opinion in microbiology, 6547-55. https://doi.org/10.1016/j.mib.2021.10.009
Ronda, Carlotta, and Wang, Harris H. "Engineering temporal dynamics in microbial communities." Current opinion in microbiology vol. 65 (2021): 47-55. doi: https://doi.org/10.1016/j.mib.2021.10.009
Ronda C, Wang HH. Engineering temporal dynamics in microbial communities. Curr Opin Microbiol. 2021 Oct 30;65:47-55. doi: 10.1016/j.mib.2021.10.009. Epub 2021 Oct 30. PMID: 34739926.
Copy Download .nbib Format: NLM
The LHC Olympics 2020 a community challenge for anomaly detection in high energy physics.

Reports on progress in physics. Physical Society (Great Britain)

Kasieczka G, Nachman B, Shih D, Amram O, Andreassen A, Benkendorfer K, Bortolato B, Brooijmans G, Canelli F, Collins JH, Dai B, De Freitas FF, Dillon BM, Dinu IM, Dong Z, Donini J, Duarte J, Faroughy DA, Gonski J, Harris P, Kahn A, Kamenik JF, Khosa CK, Komiske P, Le Pottier L, Martín-Ramiro P, Matevc A, Metodiev E, Mikuni V, Murphy CW, Ochoa I, Park SE, Pierini M, Rankin D, Sanz V, Sarda N, Seljak U, Smolkovic A, Stein G, Suarez CM, Szewc M, Thaler J, Tsan S, Udrescu SM, Vaslin L, Vlimant JR, Williams D, Yunus M.
PMID: 34736231
Rep Prog Phys. 2021 Dec 07;84(12). doi: 10.1088/1361-6633/ac36b9.

A new paradigm for data-driven, model-agnostic new physics searches at colliders is emerging, and aims to leverage recent breakthroughs in anomaly detection and machine learning. In order to develop and benchmark new anomaly detection methods within this framework, it...

Cite
Kasieczka G, Nachman B, Shih D, et al. The LHC Olympics 2020 a community challenge for anomaly detection in high energy physics. Rep Prog Phys. 2021;84(12)doi: 10.1088/1361-6633/ac36b9.
Kasieczka, G., Nachman, B., Shih, D., Amram, O., Andreassen, A., Benkendorfer, K., Bortolato, B., Brooijmans, G., Canelli, F., Collins, J. H., Dai, B., De Freitas, F. F., Dillon, B. M., Dinu, I. M., Dong, Z., Donini, J., Duarte, J., Faroughy, D. A., Gonski, J., Harris, P., Kahn, A., Kamenik, J. F., Khosa, C. K., Komiske, P., Le Pottier, L., Martín-Ramiro, P., Matevc, A., Metodiev, E., Mikuni, V., Murphy, C. W., Ochoa, I., Park, S. E., Pierini, M., Rankin, D., Sanz, V., Sarda, N., Seljak, U., Smolkovic, A., Stein, G., Suarez, C. M., Szewc, M., Thaler, J., Tsan, S., Udrescu, S. M., Vaslin, L., Vlimant, J. R., Williams, D., & Yunus, M. (2021). The LHC Olympics 2020 a community challenge for anomaly detection in high energy physics. Reports on progress in physics. Physical Society (Great Britain), 84(12), . https://doi.org/10.1088/1361-6633/ac36b9
Kasieczka, Gregor, et al. "The LHC Olympics 2020 a community challenge for anomaly detection in high energy physics." Reports on progress in physics. Physical Society (Great Britain) vol. 84,12 (2021). doi: https://doi.org/10.1088/1361-6633/ac36b9
Kasieczka G, Nachman B, Shih D, Amram O, Andreassen A, Benkendorfer K, Bortolato B, Brooijmans G, Canelli F, Collins JH, Dai B, De Freitas FF, Dillon BM, Dinu IM, Dong Z, Donini J, Duarte J, Faroughy DA, Gonski J, Harris P, Kahn A, Kamenik JF, Khosa CK, Komiske P, Le Pottier L, Martín-Ramiro P, Matevc A, Metodiev E, Mikuni V, Murphy CW, Ochoa I, Park SE, Pierini M, Rankin D, Sanz V, Sarda N, Seljak U, Smolkovic A, Stein G, Suarez CM, Szewc M, Thaler J, Tsan S, Udrescu SM, Vaslin L, Vlimant JR, Williams D, Yunus M. The LHC Olympics 2020 a community challenge for anomaly detection in high energy physics. Rep Prog Phys. 2021 Dec 07;84(12). doi: 10.1088/1361-6633/ac36b9. PMID: 34736231.
Copy Download .nbib Format: NLM
[No title available]

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer L, Gordon EM, Hornick JL, Du H, Grigorian B, Schmid AN, Hou S, Harris K, Kwiatkowski DJ, Desai NP, Dickson MA.
PMID: 34637337
J Clin Oncol. 2021 Nov 20;39(33):3660-3670. doi: 10.1200/JCO.21.01728. Epub 2021 Oct 12.

No abstract available.

Cite
Wagner AJ, Ravi V, Riedel RF, et al. . J Clin Oncol. 2021;39(33):3660-3670doi: 10.1200/JCO.21.01728.
Wagner, A. J., Ravi, V., Riedel, R. F., Ganjoo, K., Van Tine, B. A., Chugh, R., Cranmer, L., Gordon, E. M., Hornick, J. L., Du, H., Grigorian, B., Schmid, A. N., Hou, S., Harris, K., Kwiatkowski, D. J., Desai, N. P., & Dickson, M. A. (2021). . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(33), 3660-3670. https://doi.org/10.1200/JCO.21.01728
Wagner, Andrew J, et al. "." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,33 (2021): 3660-3670. doi: https://doi.org/10.1200/JCO.21.01728
Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer L, Gordon EM, Hornick JL, Du H, Grigorian B, Schmid AN, Hou S, Harris K, Kwiatkowski DJ, Desai NP, Dickson MA. . J Clin Oncol. 2021 Nov 20;39(33):3660-3670. doi: 10.1200/JCO.21.01728. Epub 2021 Oct 12. PMID: 34637337; PMCID: PMC8601264.
Copy Download .nbib Format: NLM
Platypus and echidna genomes reveal mammalian biology and evolution.

Nature

Zhou Y, Shearwin-Whyatt L, Li J, Song Z, Hayakawa T, Stevens D, Fenelon JC, Peel E, Cheng Y, Pajpach F, Bradley N, Suzuki H, Nikaido M, Damas J, Daish T, Perry T, Zhu Z, Geng Y, Rhie A, Sims Y, Wood J, Haase B, Mountcastle J, Fedrigo O, Li Q, Yang H, Wang J, Johnston SD, Phillippy AM, Howe K, Jarvis ED, Ryder OA, Kaessmann H, Donnelly P, Korlach J, Lewin HA, Graves J, Belov K, Renfree MB, Grutzner F, Zhou Q, Zhang G.
PMID: 33408411
Nature. 2021 Apr;592(7856):756-762. doi: 10.1038/s41586-020-03039-0. Epub 2021 Jan 06.

Egg-laying mammals (monotremes) are the only extant mammalian outgroup to therians (marsupial and eutherian animals) and provide key insights into mammalian evolution

Cite
Zhou Y, Shearwin-Whyatt L, Li J, et al. Platypus and echidna genomes reveal mammalian biology and evolution. Nature. 2021;592(7856):756-762doi: 10.1038/s41586-020-03039-0.
Zhou, Y., Shearwin-Whyatt, L., Li, J., Song, Z., Hayakawa, T., Stevens, D., Fenelon, J. C., Peel, E., Cheng, Y., Pajpach, F., Bradley, N., Suzuki, H., Nikaido, M., Damas, J., Daish, T., Perry, T., Zhu, Z., Geng, Y., Rhie, A., Sims, Y., Wood, J., Haase, B., Mountcastle, J., Fedrigo, O., Li, Q., Yang, H., Wang, J., Johnston, S. D., Phillippy, A. M., Howe, K., Jarvis, E. D., Ryder, O. A., Kaessmann, H., Donnelly, P., Korlach, J., Lewin, H. A., Graves, J., Belov, K., Renfree, M. B., Grutzner, F., Zhou, Q., & Zhang, G. (2021). Platypus and echidna genomes reveal mammalian biology and evolution. Nature, 592(7856), 756-762. https://doi.org/10.1038/s41586-020-03039-0
Zhou, Yang, et al. "Platypus and echidna genomes reveal mammalian biology and evolution." Nature vol. 592,7856 (2021): 756-762. doi: https://doi.org/10.1038/s41586-020-03039-0
Zhou Y, Shearwin-Whyatt L, Li J, Song Z, Hayakawa T, Stevens D, Fenelon JC, Peel E, Cheng Y, Pajpach F, Bradley N, Suzuki H, Nikaido M, Damas J, Daish T, Perry T, Zhu Z, Geng Y, Rhie A, Sims Y, Wood J, Haase B, Mountcastle J, Fedrigo O, Li Q, Yang H, Wang J, Johnston SD, Phillippy AM, Howe K, Jarvis ED, Ryder OA, Kaessmann H, Donnelly P, Korlach J, Lewin HA, Graves J, Belov K, Renfree MB, Grutzner F, Zhou Q, Zhang G. Platypus and echidna genomes reveal mammalian biology and evolution. Nature. 2021 Apr;592(7856):756-762. doi: 10.1038/s41586-020-03039-0. Epub 2021 Jan 06. PMID: 33408411; PMCID: PMC8081666.
Copy Download .nbib Format: NLM
Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK.

Drug and alcohol review

Doran J, Hope V, Wright T, Scott J, Ciccarone D, Harris M.
PMID: 34605086
Drug Alcohol Rev. 2021 Oct 03; doi: 10.1111/dar.13389. Epub 2021 Oct 03.

INTRODUCTION: People who inject drugs (PWID) are vulnerable to a range of harms, including vascular conditions such as chronic venous insufficiency (CVI), leg ulcers and deep vein thrombosis (DVT). The extent of vascular conditions has rarely been studied, despite...

Cite
Doran J, Hope V, Wright T, et al. Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK. Drug Alcohol Rev. 2021;doi: 10.1111/dar.13389.
Doran, J., Hope, V., Wright, T., Scott, J., Ciccarone, D., & Harris, M. (2021). Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK. Drug and alcohol review, . https://doi.org/10.1111/dar.13389
Doran, Jason, et al. "Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK." Drug and alcohol review vol. (2021). doi: https://doi.org/10.1111/dar.13389
Doran J, Hope V, Wright T, Scott J, Ciccarone D, Harris M. Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK. Drug Alcohol Rev. 2021 Oct 03; doi: 10.1111/dar.13389. Epub 2021 Oct 03. PMID: 34605086.
Copy Download .nbib Format: NLM
Showing 1393 to 1404 of 3124 entries